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Abstract
Until today, February 22, 2016, no confirmed Ebola cases have been diagnosed in Americas
(except USA, four cases with one death). Confusion, lack of knowledge, and fear have led
to quickly misclassify cases as suspected, when in fact most of them are false alarms.
Nevertheless, European governments summoned to mobilize resources to attend the
Ebola outbreak in West Africa. And also Latin American governments should contrib‐
ute to halt this humanitarian crisis and to be prepared for the potential arrival of this
deadly virus in the Caribbean, Central, and South American mainland. In this chapter,
we described the experience of preparedness as well as risk assessment done in Latin
America regarding the threat of Ebola for the region.
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1. Introduction
Ebola virus (EBOV) was the second genus of the Filoviridae family to be discovered. This
negative‐sense, single‐stranded RNA virus was first identified in 1976 following two simulta‐
neous outbreaks in Zaïre (now known as the Democratic Republic of Congo) and Sudan [1–4].
Since then, at least 25 subsequent outbreaks, including the ongoing outbreak in West Africa,
have occurred and various EBOV species have been identified with genetic and virulence
variability and still unknown pathogenesis. Before 2014, none of those epidemics implied
imported cases outside Africa, with its multiple implications [1–9].
Nowadays, the ongoing outbreak (almost finished) in West Africa has been the largest reported
in history, and from a global health perspective, it showed again how poverty, cultural
practices, and weak and unprepared health systems could interact exacerbating infectious
disease spread, limiting its control and mitigation, and the importance of travel in a globalized
world, since this was the first outbreak in which EBOV cases and transmission were reported
outside of Africa [5, 6, 8].
This outbreak has challenged global capability of response of world policymakers to organize
and implement resources in an impoverished and previous overlooked area, it taught the
implication of reactive rather than proactive health systems organization, and in a setting of
unpreparedness and lack of knowledge, social media played an important role in spreading
unfounded fear through false alarms [5, 6, 8].
Until today, February 14, 2016, a total of 28,639 cases and 11,316 deaths (case fatality rate [CFR
%] of 39.5%) were reported according to the World Health Organization (WHO) report of
February 17, 2016 [10]. The majority of these cases and deaths occurred between August and
December 2014, after which case incidence declined apparently associated with scale‐up of
treatment, isolation, and safe burial.
In the last 21 days, zero cases were reported in the implicated countries (Guinea, Liberia, and
Sierra Leone) and on November 7, 2015, December 29, 2015, and January 14, 2016, the WHO
declared that human‐to‐human transmission of Ebola virus has ended in Guinea, Sierra Leone,
and Liberia, respectively, if no further cases appear, entering in a period of heightened
surveillance, putting these countries in the way on recovery, and giving the chance of getting
essential health services backup and to address weaknesses to rebuild a resilient health system
[10].
Likewise, there were a total of seven cases reported outside of African continent with one death
at USA [10]. Countries involving imported cases outside Africa have been Italy, Spain, United
Kingdom, and USA (each one with one case, except USA with four cases) [11] (Figure 1),
without truly suspected cases in Latin America and the Caribbean (LAC) [6–13].
Nevertheless, European governments summoned to mobilize resources to attend the Ebola
outbreak in West Africa during the peak of the epidemics [14–16]. But also LAC governments
have been called to contribute to halt this humanitarian crisis and to be prepared for the
potential arrival of this deadly virus in the Caribbean, Central, and South American mainland,
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particularly during the peak of the epidemics in Africa. In this chapter, we described the
experience of risk assessment as well as preparedness done in Latin America regarding the
threat of Ebola for the region.
Figure 1. Confirmed, probable, and suspected EVD cases worldwide. From: WHO Ebola Situation Report – February
17, 2016.
2. Risk assessment
Some studies have provided perspectives on the potential for Ebola virus disease (EVD) to
spread across international borders via commercial air travel [17–20]. However, they have only
focused on top international destinations in Africa, Europe, Asia, and North America.
Recently, we have assessed this for Latin American countries.
During the peak of the epidemics, we gathered epidemiological data from the Ebola response
roadmap situation report of the World Health Organization (WHO) (for October 29, 2014) [20].
We included Sierra Leone, Guinea, and Liberia as officially affected regions by the EVD
epidemics. Because data concerning commercial air travel out of Guinea, Liberia, and Sierra
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Leone to LAC countries were unavailable, we used population migration data from the United
Nations’ international migrant stock by destination and origin database (estimates of the
international migrant stock exodus for the midpoint [1 July] of each year: 1990, 2000, 2010, and
2013). We assessed the number of people migrating from Guinea, Liberia, and Sierra Leone to
LAC countries in years 2000, 2010, and 2013. We also included within those numbers all
potential returns of previously deployed persons from LAC countries to affected West African
nations. We took the maximum number of migrating people from West African countries to
LAC during those three years, as the potential number of people migrating in 2014, followed
by an estimation on the prevalence of EBV in source countries (cases/100,000 pop and %), based
on WHO reports and official population estimates, gathered from the World Bank registry
data. We assumed a random distribution of prevalence among population as equal for
migrating people in order to calculate the number of potential persons migrating with EBV to
CSA countries [8].
Up to October 29, 2014, WHO reported 13,676 cases of EBV, with 6535 cases from Liberia, Sierra
Leone (5235), and Guinea (1906). During the last 21 days, 1433 active cases were reported in
Sierra Leone, 867 in Liberia, and 666 in Guinea, revealing prevalence rates for this period of
23.52 cases/100,000 pop (0.0235%), 20.19 cases/100,000 pop (0.0202%), and 5.67 cases/100,000
pop (0.0057%), respectively [8, 20].
Based on those prevalence rates and assuming migration numbers would be similar for 2014,
we estimated the potential number of people with EVD relying on each country's individual
prevalence, which resulted in a probability of less than 1 possible EVD case potentially arriving
to LAC countries. Assuming the same prevalence of active cases, migration should increase
up to 4255 persons/year from Sierra Leone, 4950 from Liberia, and 17,544 from Guinea, to reach
at least 1 case in some Latin American countries [8].
Previous reports estimated that one infected international air traveler would leave Guinea
every 2.7 months, Liberia every 0.2 months, and Sierra Leone every 0.6 months [17–20].
However, such numbers may represent an underestimate of the real situation if we take into
consideration the fact of potential cases originating from the shipping sector and spreading
through maritime transport. In addition, connection flights (e.g. Bogota, Colombia to Monro‐
via, and Liberia with connections at New York, USA, and Casablanca, Morocco) may increase
the odds of affected passengers to reach Latin America from these countries by connecting
through such alternate bridging destinations [8].
Based on the aforementioned facts, the possibility of EVD spreading to Latin America raises
concerns in regard to the capacity of healthcare institutions and laboratories in the region to
provide adequate facilities, competently trained healthcare staff, acceptable infection control
measures and equipment, supplies, protocols and resources to provide effective disease
management, diagnosis, and overall containment strategies [6, 8]. Previously, WHO published
the public health actions for early detection and prevention of transmission of Ebola and
Marburg viruses. Even in a low‐risk setting, there are significant concerns over whether Latin
American countries are ready to face EVD within their vulnerable healthcare systems [6, 8].
Fortunately, after the epidemics in Africa, none confirmed cases nor real suspected cases
arrived to Latin America, although most countries in the region, particularly Brazil and
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Colombia, were prepared for the arrival, developed national guidelines for preparedness, and
managed some false alarms properly, in most of the cases.
3. Preparedness
We acknowledged a huge need for field‐based laboratories, epidemiological and microbio‐
logical surveillance resources, diagnostic equipment, and mobile communications software as
well as other technological assets. As revealed by the ongoing chikungunya and Zika epidem‐
ics [21–25], LAC is particularly vulnerable to infectious disease spreading given that there is
a lack of appropriate healthcare infrastructure to tackle a challenge of such dimensions,
particularly from airborne (e.g. Influenza H1N1 in 2009) and vector‐borne diseases [22, 26].
However, regarding the collaboration to intervene the crisis, it is important to highlight that
the Cuban government sent a team of 165 highly trained healthcare professionals to assist and
mitigate the epidemic, being, so far, the largest medical team that any single foreign country
sent out to the field, from LAC to Africa [6, 8].
Besides that, the Pan American Health Organization (PAHO) [15], along with the WHO, have
recommended nations to implement measures based on surveillance [20], laboratory diagno‐
sis, case management, infection prevention and control, clinical management and awareness
and communication. This in order to be prepared and to have an appropriate response to the
hypothetical arrival of EVD to LAC, which as has been mentioned, was expected to be low to
very low [6, 8]. Although early detection, tracing, and isolation of truly suspected cases and
contacts would limit the risk of disease spread, the proper laboratory assessment and sample
management will be restricted given the lack of trained health personnel, protective equip‐
ment, and adequate transport particularly in some highly densely populated areas, where
poverty and deficient basic services constitute a melting point for the development of potential
outbreaks. Health personnel must be capable to manage risk group 4 pathogen, as EBOV, and
must account with protective equipment like non‐sterile gloves, masks, goggles preferably
with an anti‐fog visor and apron or waterproof apron, disposable if possible [6, 8, 16, 18].
Additionally, staff in charge of handling and transporting the samples must account with a
certification by the International Air Transport Association for shipping and handling
Category A infectious substance in order to send samples to the only two laboratories in the
region that can receive them: the National Center for Emerging Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC) and Zoonotic Diseases and
Special Pathogens, National Microbiology Laboratory, Infectious Disease and Emergency
Preparedness Branch Public Health Agency of Canada. Furthermore, as opposed to Europe,
where BSL‐4 (BSL‐4) laboratories network already exists, LAC still requires a significant
increase in technical partnership as well as other resource capabilities, BSL‐4 in LAC are scarce
what has limited the work with other important BSL‐4 required viral pathogens endemic to
the region, such as hantaviruses in the past and in the middle of current of cases of this zoonotic
viruses in Chile and other countries in the region [6, 8, 16, 18].
On the other hand, if EBOV arrives to LAC, it would pose an immense diagnostic challenge
in a region where endemic viral hemorrhagic fevers exhibit remarkable similar clinical
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findings. Distinguishing cases of Guanarito (Venezuela), Machupo (Bolivia), Junín (Argenti‐
na), and Sabiá (Brazil) viruses from Ebola, as well as from other highly prevalent infections
such as yellow fever, dengue with hemorrhagic manifestations, leptospirosis, and typhoid
fever, among others, will constitute an ever‐increasing challenge. Point‐of‐care testing using
a biothreat panel like the BioFire diagnostics BioSurveillance system would be useful for
screening highly suspicious cases, while at the same time, providing an automated sample‐to‐
answer diagnostic platform in areas with lack of healthcare trained personnel, even though
rapid diagnostic test use is discouraged given its low specificity. We still do not know how
such tests would perform in a non‐prevalent Ebola region, and at the same time, it could be
cost prohibitive for many governments in the hemisphere [6, 8, 16, 18].
Otherwise, the clinical management of those suspected and confirmed cases should be at
designated hospitals that must comply with contact isolation conditions, ideally individually
and not by cohorts of suspected or confirmed cases, appropriate provisions of personal
protective equipment, and health services with personnel trained in infection prevention and
control [6, 8, 16, 18]. These characteristics probably are lacking even in some intermediate cities
of LAC forcing to translate patients to places where these are attained and making to consider
that transport of those patients needs special protective measures too. Even more, healthcare
institutions should start joining efforts to design preparedness and response programs in order
to revamp or build up de novo infrastructure to properly address suspicious cases and prepare
healthcare professionals for caring of confirmed Ebola‐infected patients. It is also important
to coordinate this LAC response to Ebola with the guidance of the regional multilateral health
organisms: The PAHO should lead this process; and the recently created South American
Institute of Government in Health (www.isags‐unasur.org) and the South American National
Institutes of Health Network could demonstrate their ability to recruit and materialize
resources for global health [6, 8, 16, 18].
The call for attention that was the EBOV outbreak highlighted the importance of proactive
organization of health systems particularly in those settings in which poverty, social inequal‐
ity, and lack of basic healthcare services and facilities could limit action when an infectious
disease has established [6, 8, 16, 18]. Many countries in LAC have proved its restraints in
infectious disease control, as recently reported for malaria, dengue, chikungunya, and Zika in
Venezuela, and its social and economic context can act as boosters for infection spread [22,
26]. As taught, the entire world needs to turn out its look and watch for those impoverished
areas before crisis, searching to close gaps in order to reach fairer societies.
Latin America is endemic for many febrile infectious diseases conditions; then, signs and
symptoms of EVD may overlap with other acute viral hemorrhagic fevers like dengue,
chikungunya, and now Zika posing a challenge at the time of diagnosis [9]. Despite the low‐
risk for a local outbreak in LAC, the possibility of an imported case always remains latent [6,
8]. Thus, in light of such hypothetical epidemiological scenario, we also considered that
assessing knowledge and perceptions among healthcare students and workers about the
epidemiology, transmission, and clinical manifestations of Ebola in a country like Colombia
is of utmost importance; particularly, taking into account that before the 2014–2015 epidemic,
no information concerning EVD was available in Colombia's public health surveillance
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program [9]. Then, an observational, descriptive, cross‐sectional study was conducted among
107 healthcare workers attending the symposium “What we should know about Ebola?”
(organized by the Coffee Triangle regional chapter of the Colombian Association of Infectious
Diseases and the Universidad Tecnológica de Pereira) held in October (2014) in one city of
Colombia: Pereira, Risaralda [9]. Attendees who agreed to be part of the research (convenience
sample) filled out a basic knowledge questionnaire, which included aspects on the epidemi‐
ology, symptoms, and prevention of the disease (five questions). Questionnaires were
completed before and after the event. Statistical analysis was performed using the SPSS
statistical package, version 19.0. A chi‐square test (p < 0.05) was run to assess the significance
and compare observed frequencies of correct answers before and after the symposium. The
results obtained for each individual question revealed an increasing statistical significance
when comparing presurvey to postsurvey answers (p < 0.05), highlighting the pivotal role of
disease prevention, surveillance, preparedness, and response informational resources [9].
As healthcare workers, it is essential to rely on complete and updated information about
emergent diseases such as EVD, a disease which has recently been cataloged by WHO as an
international public health emergency. Unfortunately, to date, many aspects on the basic
ecology, transmission, and pathogenesis of the disease remain unclear. The possibility that
different species of bats and primates endemic to the New World could serve as hosts for the
virus remains a lurking possibility, as well as a threat to the possible arrival of this disease to
the Americas [9].
A lack of experience on how to recognize its signs and symptoms as well as how to approach
and manage outbreaks still remains a challenge in most affected countries and a most inherent
peril to unaffected regions. All in all, it is imperative to call for awareness and prepare to handle
and recognize this disease, for which world class organizations like the CDC and WHO have
already issued the necessary guidelines on how to prevent possible epidemics through early
recognition of cases, as well as how to achieve prompt institution of containment measures [9].
Due to a lack of efficient healthcare policies and systems, Latin American countries are
particularly vulnerable to infectious diseases, as it has been shown with other endemic
infectious maladies such as chikungunya, Zika, and malaria [22–26]. In view of this, besides
preparing for preventive and interventional actions, educational resources should also aim to
battle the negative impact of misinformation and fear, which may lead to jitters as a conse‐
quence of false alarm cases which occurred in fact in LAC in the middle of the epidemics of
EVD in Africa [6–9].
Informational and educational tools play on improving knowledge about clinical manifesta‐
tions and disease management among caregivers residing in non‐affected areas, as well as how
to respond if challenged to face such an unlikely event, in this case, in LAC [9].
4. False alarms
During the epidemics of Ebola in Africa and the arrival of imported cases to Europe and North
America, fear and alert were combined in LAC regarding the potential arrival of suspected
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cases of EVD in this region [6–9]. As consequence of that, confusion, lack of knowledge, and
fear led to quickly misclassify cases as suspected, when in fact most of them are false alarms.
Latin America was challenged with false alarms of “suspected” cases of EVD that not met the
criteria to be classified as real suspected cases.
Our group assessed false alarms and suspected cases in the Americas of EVD, based on online
available information on such cases. Analyzing online news information sources, data on
suspected cases were collected and the WHO Ebola fever suspected case definition reviewed
in order to classify them as suspected or false alarms.
Until April 1, 2015, 67 reports, containing 232 suspected or false alarm cases, were retrieved
from the Web in 25 American countries. From them, 79.1% corresponded to false alarms and
20.9% suspected cases (WHO complied definition). From false alarms, only 18.9% came from
Sierra Leone (13%), Liberia (4%), or Guinea (2%), but none of them presented symptoms during
last 21 days (Figure 2). Although those cases not met the definitions, were considered sus‐
pected cases and then reported as that. From real suspected cases (14), all came from Ebola
endemic places (28.6% Nigeria, 21.4% Guinea, 7.1% Liberia, 7.1% Sierra Leona), all of them
with symptoms (mostly fever) during the last 21 days (Figure 3).
Figure 2. Geographical origin of the false alarm cases.
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Figure 3. Geographical origin of the suspected cases (met WHO definition of suspected case).
Figure 4. Countries receiving false alarms and suspected cases.
With regard to the countries receiving these cases (suspected and false alarms), most corre‐
sponded to Trinidad and Tobago (11.9%), followed by Saint Vincent and the Grenadines
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(10.4%), USA (9.0%), Argentina (7.5%), Canada (7.5%), Chile (7.5%), Colombia (7.5%), and
Mexico (6.0%) (Figure 4). These findings were consistent with the risk assessment previously
performed based on the migration and travel patterns from EVD risk countries from Africa to
potential countries in LAC region, as described.
Although the possibility of Ebola spreading to Latin America always has been low, as previous
models have shown, concerns in regard to the capacity of healthcare institutions and labora‐
tories in the region are real. Even more, healthcare workers in the region are not prepared at
all. Then, actions include reinforcement of infection control actions in healthcare settings and
access to high‐quality diagnosis testing, among others, should be enhanced.
The world experienced the largest epidemic of EVD known in extension and duration to date,
since the virus was first identified back in 1976, with cases being reported beyond African
borders [1–10, 20]. There was, as a consequence, a sharp increase in the number of research
and publications related to vaccine candidates and the immunological aspects of EVD, among
other aspects [1, 6, 8]. Although not particularly affected by a large number of cases in this
current outbreak, the United States has played historically and continues to play on Ebola
research, although other countries have also contributed. Also, cooperation played a key role
among different nations, particularly between African, European, and North American
countries, but this should be enhanced for future epidemics as already occurred in 2014,
considering also the possibility in the future of suspected cases in Latin America and the
Caribbean [1, 16].
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